Constellation Brands (STZ)
(Delayed Data from NYSE)
$252.57 USD
+0.86 (0.34%)
Updated Sep 13, 2024 04:00 PM ET
After-Market: $252.63 +0.06 (0.02%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$252.57 USD
+0.86 (0.34%)
Updated Sep 13, 2024 04:00 PM ET
After-Market: $252.63 +0.06 (0.02%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
Zacks News
Founded in 1945 and headquartered in Victor, NY, Constellation Brands Inc. produces and markets beer, wine and spirits. It is the third-largest beer company and a leading, high-end wine company in the United States. It has a strong portfolio of high-quality brands, including Corona, Modelo Especial, Robert Mondavi, Kim Crawford, Meiomi and SVEDKA Vodka. The company conducts its operations in the United States, Mexico, Italy and New Zealand.
Booze Takes The Edge Off The Coronavirus
by Daniel Laboe
Alcohol sales are flying this month and online delivery services are a primary catalyst
Buy Corona Maker Constellation (STZ) Stock Before Q4 Earnings Amid Surge?
by Benjamin Rains
Constellation Brands (STZ) shares have surged 40% in the last week. So now might be time for investors to consider buying the Corona beer maker's stock before it reports its Q4 fiscal 2020 results on Friday, April 3...
JPMorgan, Wells Fargo, Walgreens, Constellation Brands and Nike are part of Zacks Earnings Preview
by Zacks Equity Research
JPMorgan, Wells Fargo, Walgreens, Constellation Brands and Nike are part of Zacks Earnings Preview
Factors Influencing Constellation Brands' (STZ) Q4 Earnings
by Zacks Equity Research
Constellation Brands' (STZ) fourth-quarter fiscal 2020 results are likely to reflect gains from the robust corona beer business, innovation pipeline and strong depletion growth.
Constellation Brands (STZ) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Constellation Brands (STZ) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Rescue Deal Impact Last? 4 Coronavirus-Proof Dividend Picks
by Urmimala Biswas
With the ongoing erratic movement of most stocks, it's a prudent idea for investors to go for dividend-paying stocks as a regular source of income.
Has the Market Bottomed Already?
by Sheraz Mian
We will discuss below whether the market has bottomed already or not, but this week's record-setting rebound has reemphasized the importance of staying invested to participate in rallies...
Why Constellation Brands (STZ) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Constellation Brands (STZ) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
The Zacks Analyst Blog Highlights: Constellation Brands, MVC Capital, DICK'S Sporting Goods, Bloomin' Brands and DRDGOLD
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Constellation Brands, MVC Capital, DICK'S Sporting Goods, Bloomin' Brands and DRDGOLD
Buy 5 Top Low-Beta High-Yielding Stocks Amid Severe Volatility
by Nalak Das
With market participants unable to estimate the extent and impact of the coronavirus crisis have begun panic selling off of risky assets like equities.
6 Consumer Staple Stocks to Withstand Virus-Induced Disturbances
by Nalak Das
A few consumer staple stocks have witnessed upward estimate revisions for 2020 earnings per share (EPS) during the past 30 days amid the coronavirus pandemic.
STZ vs. DEO: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
STZ vs. DEO: Which Stock Is the Better Value Option?
Here's Why You Should Hold on to O-I Glass Stock for Now
by Zacks Equity Research
Given its focus on innovation, capacity expansions and acquisitions, O-I Glass (OI) is worth retaining in the portfolio at the moment.
Is Coronavirus Scare Enough to Derail Diageo From Growth Path?
by Zacks Equity Research
Diageo (DEO) is among the companies that have warned of impacts from the coronavirus on its results. However, its sound fundamentals may help it rebound when conditions improve.
Constellation Brands Concludes Divesture of Ballast Point
by Zacks Equity Research
Constellation Brands (STZ) concludes sale of the Ballast Point brand and related assets to Kings & Convicts. The divesture is in sync with the company's consumer-led premiumization strategy.
Constellation Brands Stays Prim Despite Coronavirus Outbreak
by Zacks Equity Research
Constellation Brands (STZ) clarifies to investors that its fiscal 2020 sales remain unaffected by the coronavirus outbreak in China due to less international exposure.
Molson Coors (TAP) Stock Rises as Q4 Earnings Beat Estimates
by Zacks Equity Research
Molson Coors' (TAP) fourth-quarter 2019 results gain from positive global net pricing, cost savings, lower operating expenses and the timing of marketing investments. It outlines view for 2020.
Molson Coors' (TAP) Vizzy Hard Seltzer Launch Challenged (Revised)
by Zacks Equity Research
Molson Coors (TAP) faces litigation for naming its hard seltzer Vizzy. Contender Future Proof, the maker of Brizzy hard seltzer, claims that the name creates market confusion.
Here's Why Procter & Gamble's a Promising Investment Option
by Zacks Equity Research
Procter & Gamble (PG) is gaining from its cost-saving plans, strong organic sales growth and efforts to improve productivity. Also, the company is on track to improve its product portfolio.
Constellation Brands (STZ) to Gain From Corona Hard Seltzer
by Zacks Equity Research
Constellation Brands' (STZ) investment in Corona hard seltzer is likely to bolster its position in the fast-growing hard seltzer category. Its efforts to boost wine & spirits also remain robust.
Molson Coors' (TAP) Vizzy Hard Seltzer Launch Challenged
by Zacks Equity Research
Molson Coors (TAP) faces litigation for naming its hard seltzer Vizzy. Contender Future Proof, the maker of Brizzy hard seltzer, claims that the name creates market confusion.
Constellation Brands (STZ) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Constellation Brands (STZ) closed at $200.34, marking a +0.27% move from the previous day.
Constellation Brands (STZ) Up 3.2% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Constellation Brands (STZ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Hard Seltzer Demand Sets the Stage for Alcohol Industry Growth
by Rajani Lohia
Growing health-consciousness among drinkers and demand for better, refreshing beverages are putting hard seltzers in the limelight. Hard seltzer volumes are likely to more than triple by 2023.
Philip Morris (PM) Q4 Earnings Match Estimates, Revenues Beat
by Zacks Equity Research
Philip Morris' (PM) fourth-quarter 2019 results gain on favorable pricing. However, combustible category revenues remain soft.